A carregar...
Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab – a case report
Much excitement has been generated with the approval of idarucizumab, a humanized monoclonal antigen‐binding antibody fragment that is capable of reversing the anticoagulant activity of dabigatran. Here, we describe our initial experience of using tissue plasminogen activator (tPA) in an acute poste...
Na minha lista:
| Publicado no: | Ann Clin Transl Neurol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5099535/ https://ncbi.nlm.nih.gov/pubmed/27844035 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.346 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|